Assyro is a company that leverages artificial intelligence to streamline and optimize the process of regulatory submissions for pharmaceutical and biotech companies. Assyro AI automates the validation of FDA eCTD submissions, provides remediation guidance that adheres to CFR references, and ensures that regulatory submissions are inspection-ready, thereby reducing the risk of costly rework and accelerating the submission process for publishing, quality, and regulatory affairs teams.